Prof Andrew Sindone and Dr Ted Wu discuss the importance of SGLT2 inhibitors and the ground-breaking evidence that has seen this class of drugs now be recommended as second-line T2D treatment
In this Quick Case Endocrinologist A/Prof Samantha Hocking presents the obesity management case of a 36-year-old female, describes treatment options, clinical outcomes, and provides some take home messages.
In this Product Explainer, Endocrinologist A/Prof Samantha Hocking provides an update on tirzepatide injection for chronic weight management and provides a detailed demonstration of how to use the device.
Does BMI still have a role? Should we treat those with ‘pre-clinical’ obesity? Experts weigh in as focus shifts to improving health over losing weight…
In this Product Explainer, Endocrinologist A/Prof Samantha Hocking explains the role of tirzepatide injection for chronic weight management (CWM) and how to use the device.